Top Markets
Coin of the day
Harbin Pharmaceutical Group Co., Ltd. Harbin Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd.

600664
Clasificación en acciones #4983
Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical... Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical company, overseeing the complete process from drug discovery and development to manufacturing and global sales. The firm's activities span both domestic Chinese markets and international territories. Its business structure is segmented into seven key areas: Antibiotics, Small-Molecule Drug Formulations, Over-the-Counter (OTC) and Health Products, Modern Chinese Medicine, Biopharmaceutical products, Animal Vaccines, and Pharmaceutical Distribution services. The company's broad product portfolio features a comprehensive selection of penicillin and cephalosporin antibiotics, in addition to vital pharmaceutical intermediates. Its notable offerings include various types of injections, such as Shuang Huanglian and Danshen freeze-dried injections, alongside a wide array of oral medications like roxithromycin dispersible tablets, amoxicillin capsules, and specialized pediatric granules containing paracetamol. The product line also encompasses a diverse range of antibiotics, highlighted by multiple cephalosporin-based injections (e.g., ceftriaxone sodium, cefepime hydrochloride) and penicillin derivatives, alongside extracts from traditional Chinese medicine like Panax ginseng. Furthermore, the group manufactures essential medical protective gear, including disposable surgical and protective masks, as well as isolation and protective gowns. These products are distributed under numerous well-known brands, including Hongyan Yaopin, Guangwei, Renmin Tongtai, and Hayao, among others. The company's headquarters are located in Harbin, China.
Precio por acción
$1.24
Capitalización bursátil
$3.11B
Cambio (1 día)
4.28%
Cambio (1 año)
133.95%
País
CN
Comercio Harbin Pharmaceutical Group Co., Ltd. (600664)

Categoría

Historial de desdoblamientos de acciones de Harbin Pharmaceutical Group Co., Ltd. (600664)
La acción Harbin Pharmaceutical Group Co., Ltd. (símbolo: 600664) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 27, 2026.
Una acción 600664 comprada antes de Aug 27, 2026 equivaldría hoy a 0 acciones 600664.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
0 -
DE
0 -
DE
0 -
JP
0 -
CH
5 x119
IN